Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The main protease (M) of SARS-CoV-2 is an attractive target for the development of drugs to treat COVID-19. Here, we report the design, synthesis, and structure-activity relationship (SAR) studies of highly potent SARS-CoV-2 M inhibitors including TKB245 ()/TKB248 (). Since we have previously developed M inhibitors () and (), several hybrid molecules of these previous compounds combined with nirmatrelvir () were designed and synthesized. Compounds such as TKB245 () and TKB248 (), containing a 4-fluorobenzothiazole moiety at the P1' site, are highly effective in the blockade of SARS-CoV-2 replication in VeroE6 cells. Replacement of the P1-P2 amide with the thioamide surrogate in TKB248 () improved its PK profile in mice compared to that of TKB245 (). A new diversity-oriented synthetic route to TKB245 () derivatives was also developed. The results of the SAR studies suggest that TKB245 () and TKB248 () are useful lead compounds for the further development of M inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jmedchem.3c00777 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models.
Chem Pharm Bull (Tokyo)
September 2025
Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
In screening for antibacterial agents from co-cultures of Mycobacterium smegmatis and microbial resources, such as actinomycetes and fungi, the known hydroxyquinone antibiotic griseorhodin A (1) was isolated from a co-culture of actinomycete strain TMPU-20A002 and M. smegmatis. Compound 1 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE), with minimum inhibitory concentrations of 0.
View Article and Find Full Text PDFStructure activity relationship exploration of imidazo[1,2-a]pyridine series to reverse isoform selectivity and identify potent SIK1 selective inhibitors.
Bioorg Med Chem Lett
September 2025
Galapagos SASU, 102 avenue Gaston Roussel, 93230 Romainville, France. Electronic address:
The salt-inducible kinase (SIK) family encompasses three isoforms, SIK1, SIK2, and SIK3, which are members of the AMP-activated protein kinase (AMPK) family of serine/threonine protein kinases. SIK inhibition has emerged as a potential therapeutic approach across multiple indications, as SIKs regulate a diverse set of physiological processes such as metabolism, bone remodeling, immune response, malignancies, skin pigmentation, and circadian rhythm. Within isoform-specific SIK inhibitors there is a need to understand the distinct role of each protein, and here we describe the first SIK1 selective inhibitors.
View Article and Find Full Text PDFPorous SiO/ZnO-carboxymethyl cellulose composite hydrogels for enhanced hemostatic efficacy and antibacterial activity.
Int J Biol Macromol
September 2025
School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, China. Electronic address:
The development of effective hemostatic and antibacterial dressings remains a critical challenge in wound management. We report the design and fabrication of novel porous composite hydrogels composed of carboxymethyl cellulose (CMC), silica (SiO), and zinc oxide nanoparticles (ZnO NPs) . The incorporation of SiO and ZnO NPs into the CMC hydrogel matrix resulted in a unique multi-scale porous structure, characterized by interconnected holes of various sizes, which significantly enhanced the hydrogel's liquid absorption capacity and mechanical strength.
View Article and Find Full Text PDFAdvances in ERK1/2 inhibition: a medicinal chemistry perspective on structure and regulation.
J Enzyme Inhib Med Chem
December 2025
Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India.
The mitogen-activated protein kinase (MAPK) pathway-also known as the RAS/RAF/MEK/ERK pathway-is a critical signalling cascade involved in regulating cell growth, proliferation, and survival. First discovered in the early 1980s, the pathway's extracellular signal-regulated kinase (ERK) subfamily was identified in the 1990s. The ERK family includes several isoforms-ERK1, ERK2, ERK3, ERK5, and ERK6-with ERK1 (MAPK3) and ERK2 (MAPK1) being the most well-characterised and playing central roles in MAPK signalling.
View Article and Find Full Text PDFPost-translational modifications at the crossroads of cancer metabolism and immune regulation: therapeutic opportunities and challenges.
Int J Surg
September 2025
Department of Urology, The first Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Post-translational modifications (PTMs) are chemical modifications that occur on specific amino acid residues after protein biosynthesis, which can affect protein function by altering protein structure, localization and activity, thus expanding protein diversity. Extensive research has demonstrated that PTMs can regulate various metabolic processes, such as glucose and lipid metabolism, as well as immune modulation in tumor cells, thereby promoting tumor initiation, progression, and metastasis. In this article, we systematically review a class of emerging PTMs whose roles in tumor metabolism and immune regulation have gradually been recognized in recent years, including six types: lactylation, palmitoylation, SUMOylation, succinylation, crotonylation, and myristoylation.
View Article and Find Full Text PDF